Emergent BioSolutions
EBS
S$8.02
Share price
-5.30%
Change (1 day)
-1.46%
Change (1 year)
Categories
Emergent BioSolutions (EBS) Fails to deliver data
Key failure to deliver metrics for Emergent BioSolutions :
- Last SEC data release: 2025-05-14
- Last 15 days FTD volume: S$0.15 M
- Last 3 months FTD volume: S$0.51 M
- Last year FTD volume: S$0.51 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Emergent BioSolutions (EBS) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013
Volume in USD (price x number of shares), data since 2013Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | S$1.34 M | -77.44% |
| 2024 | S$5.95 M | -25.6% |
| 2023 | S$8 M | 209.82% |
| 2022 | S$2.58 M | -80.14% |
| 2021 | S$13 M | -54.52% |
| 2020 | S$28.59 M | 174.75% |
| 2019 | S$10.4 M | -22.55% |
| 2018 | S$13.43 M | 17.87% |
| 2017 | S$11.39 M | 24.65% |
| 2016 | S$9.14 M | 50.78% |
| 2015 | S$6.06 M | 23.18% |
| 2014 | S$4.92 M | 671.04% |
| 2013 | S$0.63 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Merck MRK | S$45.1 M | S$0.17 B | 🇺🇸 USA |
 SIGA Technologies SIGA | S$0.4 M | S$5.86 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$0.16 B | S$0.31 B | 🇬🇧 UK |
 Celldex Therapeutics CLDX | S$1.39 M | S$7.64 M | 🇺🇸 USA |
 Pfizer PFE | S$35.84 M | S$0.35 B | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | S$11.71 M | S$46.89 M | 🇮🇱 Israel |
 Soligenix SNGX | N/A | S$0.01 M | 🇺🇸 USA |